Genetics, ancestry, and hypertension: Implications for targeted antihypertensive therapies

Nora Franceschini, Daniel I. Chasman, Rhonda M. Cooper-DeHoff, Donna K. Arnett

Research output: Contribution to journalReview articlepeer-review

29 Scopus citations


Hypertension is the most common chronic condition seen by physicians in ambulatory care and a condition for which life-long medications are commonly prescribed. There is evidence for genetic factors influencing blood pressure variation in populations and response to medications. This review summarizes recent genetic discoveries that surround blood pressure, hypertension, and antihypertensive drug response from genome-wide association studies, while highlighting ancestry-specific findings and any potential implication for drug therapy targets. Genome-wide association studies have identified several novel loci for inter-individual variation of blood pressure and hypertension risk in the general population. Evidence from pharmacogenetic studies suggests that genes influence the blood pressure response to antihypertensive drugs, although results are somewhat inconsistent across studies. There is still much work that remains to be done to identify genes both for efficacy and adverse events of antihypertensive medications.

Original languageEnglish
Article number461
JournalCurrent Hypertension Reports
Issue number8
StatePublished - Aug 2014

Bibliographical note

Funding Information:
Rhonda M. Cooper-DeHoff has received research grants from NIH and Abbott Laboratories. She also has received a patent for clinical trial software and royalties from the University of Florida Foundation. Donna K. Arnett has received a grant from the NIH.


  • Ancestry
  • Genetics
  • Genome-wide association studies
  • Hypertension
  • Pharmacogenetics

ASJC Scopus subject areas

  • Internal Medicine


Dive into the research topics of 'Genetics, ancestry, and hypertension: Implications for targeted antihypertensive therapies'. Together they form a unique fingerprint.

Cite this